Organic compounds -- part of the class 532-570 series inventions 08/08

20080207905 - Metallic compound and organic electroluminescence device comprising the same: The present invention relates to a light emitting metallic compound of Chemical Formula 1 and an organic electroluminescence device including the compound. In the Chemical Formula 1, M is selected from Ir, Pt, Rh, Re, and Os, m is 2 or 3, n is 0 or 1, the sum of... Agent: Cantor Colburn, LLP

20080207906 - Synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs: Novel methods of synthesis of known and novel 14-hydroxyl opiates through 1-halothebaine and derivatives are described.... Agent: Mallinckrodt Inc.

20080207907 - Process for pd-catalysed c-n coupling in specific solvent systems: The invention relates to a novel process for the Pd catalysed formation of C—N bonds between an aryl halide or an aryloxysulphonyl compound and an amine in specific solvent systems, and also to the use of these solvent systems for C—N couplings.... Agent: Mcdonnell Boehnen Hulbert & Berghoff LLP

20080207908 - Processes for the preparation of piperidinyl-substituted urea compounds: Disclosed are processes for the synthesis of piperidinyl-substituted urea compounds. This invention further relates to novel intermediates prepared during this synthesis.... Agent: Foley & Lardner LLP

20080207909 - Preparation of 11c methyl iodide: A process for the preparation of 11C methyl iodide comprises coating the internal surface of a first reaction vessel with a solution of lithium aluminium hydride, wherein the first reaction vessel has an internal diameter not greater than about 1.5 mm; introducing 11C carbon dioxide into the first reaction vessel... Agent: Ge Healthcare, Inc.

20080207910 - Process for the preparation of certain substituted sulfilimines: Cyano-substituted sulfilimines are produced efficiently and in high yield from the corresponding sulfides by reaction with cyanamide and hypochlorite.... Agent: Dow Agrosciences Llc

20080200677 - Metal complexes: P

20080200678 - Metallic compound and organic electroluminescence device comprising the same: In the Chemical Formulae 1 and 2, M is Ir, Pt, Rh, Re, Os, and the like, m is 2 or 3, n is 0 or 1, the sum of m and n is 3, provided that the sum of m and n is 2 when M is Pt, X,... Agent: Cantor Colburn, LLP

20080200679 - Alpha-hydroxy, alpha-substituted methylenebisphosphonates and phosphonoacetates: The present invention relates to a method for preparing α-hydroxy, α-substituted methylenebisphosphonates and phosphonoacetates via addition of Grignard or organoindium reagents to tetraalkyl carbonylbisphosphonates and trialkyl carbonylphosphonoacetates. Also disclosed are compounds so synthesized.... Agent: Hogan & Hartson

20080200680 - Polymorph transformation of zolpidem in tablet matrix: A method for converting polymorphs of Zolpidem hemitartrate, the method comprising treating tablets comprising Zolpidem hemitartrate with heat and/or moisture.... Agent: Mallinckrodt Inc.

20080200681 - Processes for preparing palonosetron salts: The present invention provides processes for preparing Palonosetron salts, especially, the hydrochloride salt and intermediates used to prepare Palonosetron salts.... Agent: Kenyon & Kenyon LLP

20080200682 - Process of producing bleach boosters: This invention relates to a process of producing compounds, which are useful as bleach boosters, as well as to the compounds, which are obtainable using said process, and to their use.... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20080200683 - Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino) ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol: The present invention relates to a process for isolating (αS,βR)-6-bromo-α-[2-(dimethylamino)ethyl]-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol from a mixture of stereoisomeric forms of 6-bromo-α-[2-(dimethylamino)ethyl]-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol by optical resolution with chiral 4-hydroxydinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin 4-oxide or a derivative thereof, in particular (11bR)-4-hydroxydinaphtho[2,1-d:1′,2′-f][1,3,2]dioxaphosphepin 4-oxide, as resolution agent.... Agent: Philip S. Johnson Johnson & Johnson

20080200684 - Process for preparing ethyl (s)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of repaglinide: Described herein is an improved, commercially viable and industrially advantageous process for the preparation of Repaglinide intermediate, ethyl (S)-2-ethoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoate. The process provides the Repaglinide intermediate in higher yield and purity compared to the previously disclosed processes, thereby providing for production of Repaglinide and its pharmaceutically acceptable salts in high purity... Agent: Cantor Colburn, LLP

20080200685 - Method for preforming oxidation catalysts: Processes comprising providing a catalyst precursor, and heating the catalyst precursor to a temperature of at least 350° C. in an atmosphere comprising air, wherein air is fed into the atmosphere at a rate of 0.05 to 4.0 standard m3/h, and wherein the catalyst precursor is activated at a temperature... Agent: Connolly Bove Lodge & Hutz, LLP

20080194821 - Light emitting compound for electroluminescent applications: The present invention refers to light emitting compounds, especially to phosphorescent compounds useful for electroluminescent applications, for example forming a layer in OLEDs and laser applications undoped to emit visible light when excited by electric current. The compounds of the present invention comprise a core structure according to general formula... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.c.

20080194822 - Imiquimod production process: The present invention provides a process for preparing highly pure 4-amino-1-isobutyl-1H-imidazo[4,5-c]quinoline (imiquimod). The process preferably includes heating 4-chloro-1-isobutyl-1H-imidazo[4,5-c]quinoline of formula (II) with ammonia in a polar aprotic solvent at relatively moderate pressure to produce imiquimod, and optionally purifying the imiquimod. The process of the present invention can produce highly pure... Agent: Leydig Voit & Mayer, Ltd

20080194823 - Preparation of loratadine form i: A process for preparing loratadine crystalline polymorphic Form I.... Agent: Dr. Reddy's Laboratories, Inc.

20080194824 - Method for obtaining a pharmaceutically active compound, synthesis intermediates thereof and methods for obtaining them: The present invention relates to a method for obtaining Dolasetron that comprises: a) Esterification of the alcohol of formula (IV) with indole-3-carboxylic acid (compound (III)) or a reactive derivative thereof, to give a compound of formula (V), followed by step b) which includes Dieckmann reaction of the intermediate (V), by... Agent: Wolf, Block, Shorr And Solis-cohen LLP

20080194825 - Process for obtaining montelukast: e

20080194826 - Novel 4-(2-furoyl) aminopiperidienes, intermediates for synthesizing the same, processes for preparing the same and medicinal use of the same:

20080194827 - Crystalline forms of donepezil base: Novel crystalline forms of Donepezil base, processes for producing same, pharmaceutical compositions containing same and methods of treatment utilizing same are disclosed.... Agent: Martin D. Moynihan Prtsi, Inc.

20080194828 - Method of preparing esomeprazole and salts thereof: Optically pure esomeprazole and its salt can be simply prepared by dissolving (S)-(−)-binol, a weak base and the racemic form of omeprazole in a mixture of a water-compatible organic solvent and water at a high temperature, cooling the mixed solution to crystallize the inclusion complex of esomeprazole and (S)-(−)-binol, and... Agent: Sughrue Mion, Pllc

20080194829 - Process for catalytically preparing aromatic or heteroaromatic nitriles: t

20080194830 - Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines: 2-Substituted-5-(1-alkylthio)alkylpyridines are produced efficiently and in high yield.... Agent: Dow Agrosciences Llc

20080194831 - Low-viscosity ionic liquids: The present invention relates to ionic liquids of low viscosity and high electrochemical stability, in particular for use in the area of electrochemistry and as solvents for carrying out chemical reactions.... Agent: Millen, White, Zelano & Branigan, P.c.

20080188660 - Hexarylene and pentarylene tetracarboxylic acid diimides: and also a process for preparing the rylenetetracarboximides I and their use for coloring high molecular weight organic and inorganic materials, for preparing aqueous polymer dispersions which absorb in the near infrared region of the electromagnetic spectrum, for producing markings and inscriptions which absorb infrared light and are invisible to... Agent: Oblon, Spivak, Mcclelland Maier & Neustadt, P.C.

20080188661 - Method for catalytic preparation of hydromorphone and hydrocodone: d

20080188662 - Colorant compounds:

20080188663 - Process for the preparation of crystalline clopidogrel hydrogen sulphate form i: The present invention describes an improved industrial process for crystallizing polymorph Form I of (+) clopidogrel hydrogen sulphate (also called clopidogrel bisulphate) in either a Type-I solvent or a Type-II. Type I solvent is an organic solvent containing two or more functional groups with a proviso that at least one... Agent: Blank Rome LLP

20080188664 - Process for preparing montelukast sodium containing controlled levels of impurities: The present invention is directed to a process of preparing montelukast or a salt thereof with minimal amounts of impurities, such as a dehydration impurity (compound (VI)) or a cyclic ether impurity (compound (VIII)).... Agent: Marshall, Gerstein & Borun LLP

20080188665 - Process for the preparation of 2-aminomethylpiperidine: e

20080188666 - Linear phenyl-substituted indazoles and indoles, a process for their production and their use as anti-inflammatory agents: